Clinical Trial Update: Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the effect of EPA-FFA on polypectomy in Familial Adenomatous Polyposis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis

Drugs mentioned

• EPA-FFA (eicosapentaenoic acid free fatty acid)

Snippet

Sponsor: S.L.A. Pharma AG | Conditions: Familial Adenomatous Polyposis | Phase 3 | Status: ACTIVE_NOT_RECRUITING